Literature DB >> 13130482

Expression of myeloid-related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis.

Michael Frosch1, Thomas Vogl, Stephan Seeliger, Nico Wulffraat, Wietse Kuis, Dorothee Viemann, Dirk Foell, Clemens Sorg, Cord Sunderkötter, Johannes Roth.   

Abstract

OBJECTIVE: To analyze which cellular compartments are involved in the initial phase of systemic-onset juvenile rheumatoid arthritis (JRA), and to investigate the role that myeloid-related protein 8 (MRP-8) and MRP-14, two S-100 proteins that are primarily expressed in phagocytes, play in the disease.
METHODS: Skin biopsy samples obtained during patients' acute episodes of systemic-onset JRA were analyzed by immunohistochemistry and in situ hybridization. Concentrations of MRP-8/MRP-14 in serum were determined by enzyme-linked immunosorbent assay.
RESULTS: By analyzing biopsy samples from cutaneous rashes during the initial phase of systemic-onset JRA, we discovered infiltration of leukocytes expressing MRP-8 and MRP-14. Surprisingly, keratinocytes also showed de novo synthesis of these proinflammatory proteins, indicating activation of epithelial cells during systemic-onset JRA. Serum concentrations of MRP-8/MRP-14 were 120-fold higher compared with healthy controls and approximately 12-fold higher compared with patients with other inflammatory diseases. Concentrations of MRP-8/MRP-14 in patients with systemic-onset JRA fell dramatically after remission was induced.
CONCLUSION: The exceptionally high serum levels of MRP-8 and MRP-14 in active systemic-onset JRA make them prime candidates as markers for monitoring disease activity and response to treatment. Since MRP-8/MRP-14 exhibit direct effects on leukocyte adhesion to the vascular endothelium, their extensive expression in the epidermis indicates an active role for these S-100 proteins in the initial phase of this systemic autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130482     DOI: 10.1002/art.11177

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  38 in total

1.  Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease.

Authors:  Marleen I Verstege; Fiebo J W ten Kate; Susanne M Reinartz; Cornelis M van Drunen; Frederik J M Slors; Willem A Bemelman; Florry A Vyth-Dreese; Anje A te Velde
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

2.  Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies.

Authors:  K M Rostasy; J Schmidt; E Bahn; T Pfander; M Piepkorn; E Wilichowski; J Schulz-Schaeffer
Journal:  Acta Myol       Date:  2008-10

3.  A Non-Peptidic S100A9 Specific Ligand for Optical Imaging of Phagocyte Activity In Vivo.

Authors:  Tom Völler; Andreas Faust; Johannes Roth; Michael Schäfers; Thomas Vogl; Sven Hermann
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

4.  Serum microRNAs as Potential Biomarkers of Juvenile Idiopathic Arthritis.

Authors:  Yasuko Kamiya; Jun-ichi Kawada; Yoshihiko Kawano; Yuka Torii; Shinji Kawabe; Naomi Iwata; Yoshinori Ito
Journal:  Clin Rheumatol       Date:  2015-04-07       Impact factor: 2.980

Review 5.  The danger from within: alarmins in arthritis.

Authors:  Meriam Nefla; Dirk Holzinger; Francis Berenbaum; Claire Jacques
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

6.  Sleep Fragmentation and Biomarkers in Juvenile Idiopathic Arthritis.

Authors:  Teresa M Ward; Weichao Yuwen; Joachim Voss; Dirk Foell; Faekah Gohar; Sarah Ringold
Journal:  Biol Res Nurs       Date:  2015-10-27       Impact factor: 2.522

7.  The role of serum myeloid-related protein 8/14 complex in Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki; Shinichirou Ohara; Yusaku Abe; Masahiro Watanabe; Kazuhide Suyama; Masatoki Sato; Koichi Hashimoto; Mitsuaki Hosoya
Journal:  Pediatr Nephrol       Date:  2011-07-16       Impact factor: 3.714

8.  Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.

Authors:  Xuefeng B Ling; Jane L Park; Tanya Carroll; Khoa D Nguyen; Kenneth Lau; Claudia Macaubas; Edward Chen; Tzielan Lee; Christy Sandborg; Diana Milojevic; John T Kanegaye; Susanna Gao; Jane Burns; James Schilling; Elizabeth D Mellins
Journal:  Proteomics       Date:  2010-11-23       Impact factor: 3.984

9.  Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.

Authors:  Miriam García-Arias; Dora Pascual-Salcedo; Susana Ramiro; Marie-Eve Ueberschlag; Thomas M Jermann; Carlos Cara; Emilio Martín-Mola; Alejandro Balsa
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

10.  Low pretreatment levels of myeloid-related protein-8/14 and C-reactive protein predict poor adherence to treatment with tumor necrosis factor inhibitors in juvenile idiopathic arthritis.

Authors:  Mikel Alberdi-Saugstrup; Susan Nielsen; Pernille Mathiessen; Claus Henrik Nielsen; Klaus Müller
Journal:  Clin Rheumatol       Date:  2016-08-25       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.